FDA 483 - Amgen Technology (Ireland) Unlimited Company - September 08, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Amgen Technology (Ireland) Unlimited Company in Dun Laoghaire, Ireland, revealed significant deficiencies in drug product manufacturing. Observations included failures in establishing adequate process controls for sterile filling and stoppering equipment, leading to potential contamination risks. Additionally, the firm was cited for inadequate revalidation of equipment systems and poor maintenance of equipment and facilities supporting drug product manufacture.
- Inspection Date
- September 8, 2025
- Product Type
- Drugs
ID · ed2f7364-851f-4cd9-b023-2e00dd6ca113